Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Erika Tissino(Centro di Riferimento Oncologico), Antonella Zucchetto(Centro di Riferimento Oncologico)
Cited by 93
Related Papers
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents
|Cytometry Part B Clinical Cytometry|2015|54
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
|Nature Communications|2022|42